Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Market Cap	35.15B
Revenue (ttm)	7.07B
Net Income (ttm)	1.47B
Shares Out	111.93M
EPS (ttm)	13.16
PE Ratio	23.86
Forward PE	20.79
Dividend	5.20 (1.66%)
Ex-Dividend Date	Jul 23, 2025

Volume	104,623
Average Volume	389,194
Open	311.20
Previous Close	314.00
Day's Range	306.20 - 315.05
52-Week Range	257.90 - 411.40
Beta	0.35
RSI	43.31
Earnings Date	Nov 12, 2025

About NSE:ADVENZYMES

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1957
• Employees: 338
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ADVENZYMES

Financial Performance

In 2024, NSE:ADVENZYMES's revenue was 6.37 billion, an increase of 2.09% compared to the previous year's 6.24 billion. Earnings were 1.31 billion, a decrease of -1.64%.